Randomized Phase 2 Study in BRAF Mutated CRC Patients - 101341

Spotlight
Video

Randomized Phase 2 Study in BRAF Mutated CRC Patients

obr has 300 videos Subscribe Here

Loading........
Description: Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute gives an overview of the outcomes of the randomized phase 2 study in BRAF mutated patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, CA.
Shared By : obr
Posted on : 01/23/17
Added : 1 year ago
Category : Colorectal Cancer